APIMEDS PHARMACEUTICALS US I
APUS·03771D102·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-Activist
APUS (APIMEDS PHARMACEUTICALS US I) is held by 5 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($57,289), GEODE CAPITAL MANAGEMENT, LLC ($31,602), VANGUARD FIDUCIARY TRUST CO ($21,635). Net institutional sentiment: Mixed.
5
Holders
$135,555
Total Value
50% (4)
Consensus
2 buying - 2 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 13, 2026 · Insiders May 20, 2025 · Activists May 7, 2026 · Congress none
ActivistINInscobee Inc.16.7%May 7, 2026
ActivistAYAyrton Capital LLC10.0%Feb 11, 2026
InsiderECEmerson Erik C.Vest 750K shMay 16, 2025
Checking access…
Top Holders
Checking access…
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer